Management of Nausea and Vomiting in Pregnancy
Start with first-line antiemetics (antihistamines, phenothiazines, or doxylamine/pyridoxine) immediately when pharmacologic treatment is needed, and escalate to ondansetron or metoclopramide as second-line agents if symptoms persist. 1
Severity Assessment
Before initiating treatment, classify severity using validated tools:
- Use the PUQE (Pregnancy-Unique Quantification of Emesis) or HELP (HyperEmesis Level Prediction) scores to objectively assess symptom severity 1
- Do not rely on ketonuria to assess dehydration severity - this is not a valid indicator 1
Stepwise Pharmacologic Management
First-Line Antiemetics (Grade A Evidence)
Prescribe these initially for nausea and vomiting in pregnancy (NVP) or hyperemesis gravidarum (HG):
- H1-antihistamines (e.g., cyclizine, promethazine - 15% of prescriptions in practice) 1, 2
- Phenothiazines (e.g., prochlorperazine - 21% of prescriptions) 1, 2
- Doxylamine/pyridoxine (Xonvea®) 1
These medications have robust safety and efficacy data and should be your starting point.
Second-Line Antiemetics
When first-line agents fail, escalate promptly:
Ondansetron (Grade B):
- Safe and effective as second-line therapy 1
- Do not discourage its use - while there is a very small absolute risk increase in orofacial clefting with first-trimester use, this must be balanced against the significant risks of poorly managed HG 1
- Women can be reassured about this minimal risk
Metoclopramide (Grade B):
- Safe and effective, can be used alone or combined with other antiemetics 1
- Use as second-line due to extrapyramidal side effect risk 1
- Critical administration detail: Give IV doses as slow bolus over at least 3 minutes to minimize extrapyramidal effects 1
- Used in 10% of primary care prescriptions 2
Combination Therapy
Use combinations of different antiemetic classes when single agents fail - this is standard practice for refractory cases 1
Non-Pharmacologic and Supportive Management
Dietary and Lifestyle Modifications
- Small, frequent, bland, dry meals high in protein 3
- Trigger avoidance 3
- Consider ginger supplementation 4
Intravenous Hydration (When Needed)
Use normal saline (0.9% NaCl) with additional potassium chloride in each bag, guided by daily electrolyte monitoring 1
Critical Thiamine Supplementation
Give thiamine to ALL women admitted with vomiting or severely reduced dietary intake, especially before administering dextrose or parenteral nutrition:
- Oral: 100 mg three times daily, OR
- IV: Vitamin B complex (Pabrinex®) 1
This prevents Wernicke's encephalopathy, a serious complication.
Important Clinical Pitfalls
Screen for Previous Adverse Reactions
Always ask about prior antiemetic reactions before prescribing, and stop medications immediately if adverse effects occur 1
Early Treatment Prevents Escalation
Most women admitted to hospital (62%) had no antiemetics prescribed beforehand 2. This represents a critical gap - early recognition and treatment in primary care may prevent hospitalizations. Don't wait for severe symptoms to develop before initiating pharmacologic therapy.
Admission Criteria
Consider hospitalization for:
- Inability to tolerate oral intake
- Dehydration requiring IV fluids
- Electrolyte abnormalities
- Refractory symptoms despite combination therapy 3
Refractory Cases
For severe, persistent symptoms:
- Consider corticosteroids 3
- Rarely, supplemental enteral or parenteral nutrition may be necessary 3
- All therapeutic measures should be exhausted before considering termination of pregnancy 1
Key Evidence Strength
The 2024 BJOG Green-Top Guideline No. 69 1 provides the most current, comprehensive, and authoritative recommendations, endorsed by multiple UK medical colleges including RCEM, AEPU, GPCPC, and supported by RCGP. This guideline emphasizes that NVP affects up to 90% of pregnant women and is one of the most common reasons for hospital admission, making proper management essential for maternal quality of life and preventing serious complications.